Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

5.8%

86 terminated/withdrawn out of 1471 trials

Success Rate

90.7%

+4.2% vs industry average

Late-Stage Pipeline

15%

221 trials in Phase 3/4

Results Transparency

10%

87 of 838 completed trials have results

Key Signals

239 recruiting87 with results71 terminated15 withdrawn

Enrollment Performance

Analytics

N/A

796(66.7%)

Phase 3

141(11.8%)

Phase 2

125(10.5%)

Phase 4

80(6.7%)

Phase 1

47(3.9%)

Early Phase 1

5(0.4%)

1194Total

N/A(796)

Phase 3(141)

Phase 2(125)

Phase 4(80)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1471)

Showing 20 of 1471 trials

NCT07643389Not ApplicableCompleted

EXCEL-Punjabi: A Culturally Tailored Exercise Oncology Pilot Feasibility Intervention

Role: collaborator

NCT07023744Phase 2Not Yet Recruiting

CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children

Role: collaborator

NCT05446597Not ApplicableCompleted

SMART Concussion Trial: Symptom Management vs Alternative Randomized Treatment of Concussion Trial

Role: collaborator

NCT05754840Phase 1Recruiting

CANnabinoids in Pediatric ONCology

Role: collaborator

NCT05806645Not ApplicableRecruiting

UPTAKE: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events

Role: collaborator

NCT06641791Phase 3Recruiting

Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer

Role: collaborator

NCT05534711Active Not Recruiting

The Family Stress Study - Chronic Stress and Child Adiposity: Testing a Bio-behavioural Model

Role: collaborator

NCT07634237Not ApplicableNot Yet Recruiting

Personalized Nutritional Intervention in Patients Undergoing TIPS Insertion for Refractory Ascites to Prevent Overt Hepatic Encephalopathy

Role: collaborator

NCT07297667Phase 1Recruiting

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Role: collaborator

NCT07312409Recruiting

Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?

Role: collaborator

NCT07628309Not ApplicableRecruiting

CanSOLVE 2.0 Theme 3.1 Mind the Gap - Dialectical Behavioural Therapy (DBT) Skills Training Program Pilot

Role: collaborator

NCT06405542Phase 1Active Not Recruiting

Exercise-based Rehabilitation to Treat Persistent Chemotherapy Induced Peripheral Neuropathy (CIPN)

Role: collaborator

NCT07625137Not ApplicableNot Yet Recruiting

Preventing Ovarian Cancer Through Opportunistic Salpingectomy at the Time of Laparoscopic Cholecystectomy

Role: collaborator

NCT05061368Phase 2Recruiting

Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD

Role: collaborator

NCT06508164Recruiting

International CRDS Registry

Role: collaborator

NCT06296992Not ApplicableRecruiting

Type 1 Diabetes, Exercise and Mentoring Trial

Role: collaborator

NCT06188689Not ApplicableRecruiting

Evaluation of A Clinical Diagnostic Test for CRDS

Role: collaborator

NCT05713630Phase 3Recruiting

The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma

Role: collaborator

NCT06119464Not ApplicableActive Not Recruiting

Re-Purposing the Ordering of 'Routine' Laboratory Tests in Hospitalized Medical Patients (RePORT Study)

Role: collaborator

NCT06884540Not ApplicableRecruiting

Optimizing Patient-centred Outcomes Using Opioid Minimization Strategies: The OPUS Anesthesia Pilot Trial

Role: collaborator